|
|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Other amyloidosis
ICD-10 (CM) Code and Descriptor
|
E85.81 |
Light chain (AL) amyloidosis
|
E8581 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.66%
|
20.50%
|
12.73%
|
5.63%
|
2.78%
|
1.98%
|
1.09%
|
0.66%
|
0.53%
|
0.40%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E85.81*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
9,345
|
9,350
|
|
80053
|
COMPREHEN METABOLIC PANEL |
8,412
|
8,416
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
7,044
|
7,074
|
|
83883
|
ASSAY NEPHELOMETRY NOT SPEC |
6,424
|
10,068
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
6,375
|
14,238
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
5,567
|
5,598
|
|
84165
|
PROTEIN E-PHORESIS SERUM |
5,122
|
5,125
|
|
J9041
|
INJECTION, BORTEZOMIB, 0.1MG |
4,769
|
89,613
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
4,528
|
5,498
|
|
86334
|
IMMUNOFIX E-PHORESIS SERUM |
4,179
|
4,212
|
|
J9144
|
DARATUMUMAB, HYALURONIDASE |
3,072
|
545,827
|
|
83880
|
ASSAY OF NATRIURETIC PEPTIDE |
2,837
|
2,857
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
2,173
|
2,174
|
|
84484
|
ASSAY OF TROPONIN QUANT |
2,112
|
2,120
|
|
83520
|
IMMUNOASSAY QUANT NOS NONAB |
2,017
|
2,737
|
|
84156
|
ASSAY OF PROTEIN URINE |
1,879
|
1,925
|
|
83735
|
ASSAY OF MAGNESIUM |
1,738
|
1,742
|
|
86335
|
IMMUNFIX E-PHORSIS/URINE/CSF |
1,570
|
1,601
|
|
96413
|
CHEMO IV INFUSION 1 HR |
1,564
|
1,564
|
|
J8540
|
ORAL DEXAMETHASONE |
1,559
|
69,653
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E85.81 related to the following DRG Codes:
545-547
|
